检索结果-南通市图书馆

Nano Materials Science 2022年第2期4卷 151-168页

作者： man kwan law Ying Zhao Weibin Zhang Rui Wang Mingcheng Shi Yunxiao Zhang Shusheng Chen Jinglei Yang Department of Mechanical and Aerospace Engineering The Hong Kong University of Science and TechnologyClear Water BayHong Kong SARChina

Highly transparent and super-wettable nanocoatings for multifunctional applications with outstanding physical properties are in high ***,such nanocoatings resistant to water invasion and Ultraviolet(UV)weathering remain a significant *** this work,physically durable coatings based on inorganic nanoparticles(NPs)and an organic segment(isocyanate-silane modified surfactant)have been synthesized via a sol-gel *** is noteworthy the isocyanate-silane with-NH-C=O-functional group creates a strong bonding between the highly hydrophilic surfactant and the inorganic *** in-house synthesized organic segment can render the coating long-lasting wetting properties and resist to be washed away by water,while the inorganic NPs can form sturdy covalent bonds with the nano-scale hierarchical structure on the glazing substrate to improve the *** nanocoating demonstrates high transparency with superwetting property(water contact angle,WCA=4.4±0.3°),effective de-frosting *** invasion or UV accelerated weathering tests do not significantly affect the self-cleaning performance of *** properties,including coating adhesion,hardness,Young's modulus,and abrasion resistance are systematically ***,this clear coating shows prominent infrared shielding property attributed to Antimony-doped tin oxide(Sb-doped SnO_(2))*** developed nanocoating process is easy to scale up for larger areas that require multipurpose self-cleaning functions.

关键词： Nanocoating Sol-gel approach Multifunctionality High transparency Superwetting Durability

Targeting calcium signaling in Alzheimer’s disease: challenges and promising therapeutic avenues

在线全文

学校读者我要写书评

暂无评论

Neural Regeneration Research 2024年第3期19卷 501-502页

作者： LinLin Song YongPei Tang Betty Yuen kwan law Neher’s Biophysics Laboratory for Innovative Drug Discovery State Key Laboratory of Quality Research in Chinese MedicineMacao University of Science and TechnologyMacao Special Administration RegionChina

The critical role of calcium dyshomeostasis in the pathogenesis of Alzheimer’s disease(AD):AD is a progressive neurodegenerative disease characterized by cognitive decline,memory impairment,and behavioral *** an estimated 50 million people being affected worldwide,the incidence of AD is constantly increasing *** hallmark of AD is the accumulation of amyloid-beta protein(Aβ)in the form of amyloid plaques and hyperphosphorylated tau protein in the form of neurofibrillary ***,increasing evidence suggests that calcium ion(Ca2+)dysregulation also plays a crucial role in the pathogenesis of AD(Calvo-Rodriguez and Bacskai,2021).As a key second messenger,Ca2+regulates a wide range of cellular processes,including the release of neurotransmitters,gene expression,and cell ***^(2+)also regulates the activity of Calcium/calmodulin-dependent protein kinase II,which is critical for synaptic plasticity,learning,and memory(Kaushik et al.,2022).Alternation in the Ca^(2+)signal is an early event in the pathogenesis of AD,which can lead to synaptic dysfunction,neuronal loss,and cognitive impairment.

关键词： Alzheimer homeostasis globally

Role of Intrahepatic Regional Immunity in Post-Transplant Cancer Recurrence

在线全文

学校读者我要写书评

暂无评论

Engineering 2022年第3期8卷 57-64页

作者： Jiang Liu Chung Mau Lo kwan man Hepatopancreatobiliary Center Beijing Tsinghua Changgung HospitalTsinghua UniversityBeijing 102218China Department of Surgery HKU-Shenzhen Hospital&LKS Faculty of MedicineThe University of Hong KongHong Kong 999077China

Hepatic malignancy is a major indication for liver transplantation;however,post-tra ns plant cancer recurrence is an emerging clinical challenge affecting long-term ***-tra ns plant tumor biology,staging,and post-transplant immunosuppression regimens have been elucidated as risk factors for recurrent liver ***,increasing evidence indicates that hepatic ischemia and reperfusion(IR)injury to allografts are crucial to providing a favorable immunologic microenvironment for cancer cell invasiveness and metastasis after liver *** association of severe graft injury in marginal grafts,such as small-for-size or fatty grafts,with lower recurrence-free survival rates in living donor liver transplantations,substantiates the correlation between hepatic IR injury and cancer *** has been demonstrated to trigger intrahepatic immunological microenvironment remodeling,including pro-inflammatory responses exacerbating graft injury and anti-inflammatory responses promoting tissue ***,the role of regional immunity in post-transplant cancer recurrence is not comprehensively *** review describes the up-to-date evidence of the intrahepatic humoral microenvironment and regional regulatory immunological microenvironment induced by IR injury,as well as their roles in cancer recurrence after liver transplantation.A comprehensive understanding of regional immunity will provide novel precise diagnostic,therapeutic,and prognostic strategies for post-transplant cancer recurrence.

关键词： Liver transplantation Liver cancer Recurrence Immunology

Impacts of wetting-drying cycles on short-term carbon and nitrogen dynamics in Amynthas earthworm casts

在线全文

学校读者我要写书评

暂无评论

Pedosphere 2021年第3期31卷 423-432页

作者： Michelle man Suet law Derrick Yuk Fo LAI Department of Geography and Resource management The Chinese University of Hong KongShatinNew TerritoriesHong Kong SARChina Department of Biology Hong Kong Baptist UniversityKowloon TongKowloonHong Kong SARChina Centre for Environmental Policy and Resource management The Chinese University of Hong KongShatinNew TerritoriesHong Kong SARChina

Effects of earthworm casts on soil nutrient dynamics and their responses to changing moisture availability in subtropical ecosystems remain poorly *** study aimed to examine short-term carbon(C)and nitrogen(N)dynamics and their interactions with wetting-drying cycles in three different structural forms(i.e.,granular,globular,and heap-like)of Amynthas earthworm *** rates of C and N mineralization in the earthworm casts were examined under two different wetting-drying cycles(i.e.,2-d and 4-d wetting intervals)using a rainfall simulation *** three simulated rainfall events,subsamples of the earthworm casts were further incubated for 4 d for the determination of CO2 and N2O *** results of this study indicated that the impacts of wetting-drying cycles on the short-term C and N dynamics were highly variable among the three cast forms,but wetting-drying cycles significantly reduced the cumulative CO2 and N2O fluxes by 62%-83%and 57%-85%,respectively,when compared to the control without being subjected to any rainfall *** C mineralization rates in different cast forms were affected by the amount of organic substrates and N content in casts,which were associated with the food preference and selection of ***,the cumulative N2O fluxes did not differ among the three cast *** wetting and drying of casts not only enhanced aggregate stability by promoting bonds between the cast particles,but also inhibited microbial survival and growth during the prolonged drying period,which together hindered decomposition and *** findings demonstrated that the interactions between the structural forms,aggregate dynamics,and C and N cycling in the earthworm casts were highly complex.

关键词： aggregate stability Cand N cycling earthworm activity earthworm casting greenhouse gas flux mineralization organic matter rainfall simulation

Transfusion-transmitted hepatitis E:What we know so far?

在线全文

学校读者我要写书评

暂无评论

World Journal of Gastroenterology 2022年第1期28卷 47-75页

作者： Carmen Ka man Cheung Sunny Hei Wong Alvin Wing Hin law man Fai law Medicine and Therapeutics Prince of Wales HospitalHong Kong 852China Institute of Digestive Disease and Department of Medicine and Therapeutics the Chinese University of Hong KongHong Kong 852China Lee Kong Chian School of Medicine Nanyang Technological UniversitySingapore 639798Singapore West Island School Hong Kong 852China

Hepatitis E virus(HEV)is a major cause of viral hepatitis *** is growing concern about transfusion-transmitted HEV(TT-HEV)as an emerging global health *** can potentially result in chronic infection in immunocompromised patients,leading to a higher risk of liver cirrhosis and even *** 0.0013%and 0.281%of asymptomatic blood donors around the world have HEV viremia,and 0.27%to 60.5%have anti-HEV immunoglobulin *** is infectious even at very low blood concentrations of the *** patients who develop persistent hepatitis E infection should have their immunosuppressant regimen reduced;ribavirin may be considered as *** interferon can be considered in those who are refractory or intolerant to ***,a nucleotide analog,showed modest antiviral activity in some clinical studies but sustained viral response was not ***,rescue treatment remains an unmet *** need for HEV screening of all blood donations remains *** screening has been adopted in some countries after consideration of risk and resource *** pathogen reduction methods have also been proposed to reduce the risk of *** studies are needed to define the incidence of transmission through transfusion,their clinical features,outcomes and prognosis.

关键词： Hepatitis E virus Acute and chronic hepatitis Immunosuppression Blood transfusion Transplantation

Efficacy of Vaccine Protection Against COVID-19 Virus Infection in Patients with Chronic Liver Diseases

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Journal of Clinical and Translational Hepatology 2023年第3期11卷 718-735页

作者： Carmen Ka man Cheung Kimmy Wan Tung law Alvin Wing Hin law man Fai law Rita Ho Sunny Hei Wong Department of Medicine and Therapeutics Prince of Wales HospitalHong KongChina West Island School Hong KongChina Department of Medicine North District HospitalHong KongChina Institute of Digestive Disease and Department of Medicine and Therapeutics State Key Laboratory of Digestive DiseaseLi Ka Shing Institute of Health SciencesThe Chinese University of Hong KongHong KongChinaLee Kong Chian School of MedicineNanyang Technological UniversitySingapore

The outbreak of coronavirus disease 2019 (COVID-19) has resulted in significant morbidity and mortality worldwide. Vaccination against coronavirus disease 2019 is a use-ful weapon to combat the virus. Patients with chronic liver diseases (CLDs), including compensated or decompensated liver cirrhosis and noncirrhotic diseases, have a decreased immunologic response to coronavirus disease 2019 vaccines. At the same time, they have increased mortality if infected. Current data show a reduction in mortality when patients with chronic liver diseases are vaccinated. A suboptimal vac-cine response has been observed in liver transplant recipi-ents, especially those receiving immunosuppressive therapy, so an early booster dose is recommended to achieve a better protective effect. Currently, there are no clinical data com-paring the protective efficacy of different vaccines in patients with chronic liver diseases. Patient preference, availability of the vaccine in the country or area, and adverse effect profiles are factors to consider when choosing a vaccine. There have been reports of immune-mediated hepatitis after coronavi-rus disease 2019 vaccination, and clinicians should be aware of that potential side effect. Most patients who developed hepatitis after vaccination responded well to treatment with prednisolone, but an alternative type of vaccine should be considered for subsequent booster doses. Further prospec-tive studies are required to investigate the duration of immu-nity and protection against different viral variants in patients with chronic liver diseases or liver transplant recipients, as well as the effect of heterologous vaccination.

关键词： COVID-19 SARS-CoV-2 Chronic liver disease Liver transplanta-tion Vaccine mRNA.

Development of An ICR Mouse Bioassay for Toxicity Evaluation in Neurotoxic Poisoning Toxins-Contaminated Shellfish

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Biomedical and Environmental Sciences 2013年第5期26卷 346-364页

作者： WONG Chun kwan HUNG Patricia KAM Kai man Biotoxin Laboratory Microbiology DivisionPublic Health Laboratory Services BranchCentre for Health ProtectionDepartment of HealthShek Kip MeiKowloon

Objective To develop an ICR （female） mouse bioassay （MBA） for toxicity confirmation and evaluation of neurotoxins （brevetoxins）-contaminated shellfish. Methods Brevetoxins （BTX-B） as a causative agent of neurotoxic shellfish poisoning （NSP） under different shellfish matrices were intraperitoneally injected at different doses into mice to study their toxic effects and to differentiate the range of lethal and sublethal dosages. Their sensitivity and specificity were analyzed with 2 competitive ELISA kits for quantitative determination of standard BTX-B and dihydroBTX-B under different shellfish matrix-diluent combinations. Detection rates of MBA and two antibody-based assays for BTX-B from field NSP-positive shellfish samples were compared. Results BTX-B could be detected in shellfish tissues at concentration of 50-400 μg/100 g under shellfish matrix-Tween-saline media, which were appropriate to identify toxic shellfish at or above the regulatory limit （80 μg/100 g shellfish tissues）. The LD 50 identified was 455 g/kg for BTX-B under general shellfish matrices （excluding oyster matrices） dissolved in Tween-saline. The presence of shellfish matrices, of oyster matrices in particular, retarded the occurrence of death and toxicity presentation in mice. Two antibody-based assays, even in the presence of different shellfish matrix-diluent combinations, showed acceptable results in quantifying BTX-B and dihydroBTX-B well below the regulatory limit. Conclusion The two ELISA analyses agree favorably （correlation coefficient, r 0.96; Student＇s t-tests, P〉0.05） with the developed bioassay.

关键词： Antibody-based assay Brevetoxin ICR female mice LD 50 Mouse bioassay Neurotoxic shellfish poisoning

Prevention and management of hepatitis B virus reactivation in patients with hematological malignancies in the targeted therapy era

在线全文

学校读者我要写书评

暂无评论

World Journal of Gastroenterology 2023年第33期29卷 4942-4961页

作者： Joyce Wing Yan Mak Alvin Wing Hin law Kimmy Wan Tung law Rita Ho Carmen Ka man Cheung man Fai law Department of Medicine and Therapeutics Prince of Wales HospitalHong Kong 852China West Island School Hong Kong 852China Department of Medicine North District HospitalHong Kong 852China

Hepatitis due to hepatitis B virus(HBV)reactivation can be serious and potentially fatal,but is *** reactivation is most commonly reported in patients receiving chemotherapy,especially rituximab-containing therapy for hematological malignancies and those receiving stem cell *** with inactive and even resolved HBV infection still have persistence of HBV genomes in the *** expression of these silent genomes is controlled by the immune *** or ablation of immune cells,most importantly B cells,may lead to reactivation of seemingly resolved HBV ***,all patients with hematological malignancies receiving anticancer therapy should be screened for active or resolved HBV infection by blood tests for hepatitis B surface antigen(HBsAg)and antibody to hepatitis B core *** found to be positive for HBsAg should be given prophylactic antiviral *** patients with resolved HBV infection,there are two *** first is pre-emptive therapy guided by serial HBV DNA monitoring,and treatment with antiviral therapy as soon as HBV DNA becomes *** second approach is prophy-lactic antiviral therapy,particularly for patients receiving high-risk therapy,especially anti-CD20 monoclonal antibody or hematopoietic stem cell *** and tenofovir are the preferred antiviral *** new effective therapies for hematological malignancies have been introduced in the past decade,for example,chimeric antigen receptor(CAR)-T cell therapy,novel monoclonal antibodies,bispecific antibody drug conjugates,and small molecule inhibitors,which may be associated with HBV *** there is limited evidence to guide the optimal preventive measures,we recommend antivi-ral prophylaxis in HBsAg-positive patients receiving novel treatments,including Bruton’s tyrosine kinase inhibitors,B-cell lymphoma 2 inhibitors,and CAR-T cell *** studies are needed to determine the risk o

关键词： Hepatitis B Hematologic neoplasms Chimeric antigen receptor-T cell therapy Monoclonal antibodies Bruton’s tyrosine kinase inhibitors Antiviral agents

A green light-enhanced cytosolic protein delivery platform based on BODIPY-protein interactions

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Nano Research 2023年第1期16卷 1042-1051页

作者： Yang Zhou Yifan Gao Li Pang Weirong Kang kwan man Weiping Wang State Key Laboratory of Pharmaceutical Biotechnology The University of Hong KongHong KongChina Department of Pharmacology and Pharmacy Li Ka Shing Faculty of MedicineThe University of Hong KongHong KongChina Dr.Li Dak-Sum Research Centre The University of Hong KongHong KongChina Department of Surgery School of Clinical MedicineHKU-SZH&LKS Faculty of MedicineThe University of Hong KongHong KongChina

Development of cytosolic protein delivery platforms brings new possibilities for various incurable *** based on polymer/protein self-assembly have shown their potential in protein ***,versatile photocontrolled platforms based on self-assembly for protein delivery are seldom ***,we report a boron-dipyrromethene(BODIPY)-modified polyamidoamine(PAMAM)with excellent photo-controllability and efficiency for the cytosolic delivery of various *** serum stability was achieved by coating hyaluronic acid and human serum albumin on the surface of BODIPY-modified PAMAM/protein *** nanoparticles under green light irradiation allowed efficient intracellular delivery of multiple cargo proteins with different charges and molecular weights and promoted endosome *** study provides valuable guidance for the development of BODIPY derivative-based protein delivery systems and advances the research in intracellular protein delivery.

关键词： photoresponsive nanoparticles intracellular delivery protein delivery polyamidoamine(PAMAM) boron-dipyrromethene(BODIPY)

Gastrointestinal and hepatic side effects of potential treatment for COVID-19 and vaccination in patients with chronic liver diseases

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

World Journal of Hepatology 2021年第12期13卷 1850-1874页

作者： man Fai law Rita Ho Kimmy Wan Tung law Carmen Ka man Cheung Department of Medicine and Therapeutics Prince of Wales HospitalThe Chinese University of Hong KongHong KongChina Department of Medicine North District HospitalHong KongChina West Island School Hong KongChina

The outbreak of coronavirus disease 2019(COVID-19)is a global *** clinical trials have been performed to investigate potential treatments or vaccines for this disease to reduce the high morbidity and *** drugs of higher interest include umifenovir,bromhexine,remdesivir,lopinavir/ritonavir,steroid,tocilizumab,interferon alpha or beta,ribavirin,fivapiravir,nitazoxanide,ivermectin,molnupiravir,hydroxychloroquine/chloroquine alone or in combination with azithromycin,and ***(GI)symptoms and liver dysfunction are frequently seen in patients with COVID-19,which can make it difficult to differentiate disease manifestations from treatment adverse *** symptoms of COVID-19 include anorexia,dyspepsia,nausea,vomiting,diarrhea and abdominal *** injury can be a result of systemic inflammation or cytokine storm,or due to the adverse drug effects in patients who have been receiving different *** monitoring of liver function should be ***-19 vaccines have been rapidly developed with different technologies including mRNA,viral vectors,inactivated viruses,recombinant DNA,protein subunits and live attenuated *** with chronic liver disease or inflammatory bowel disease and liver transplant recipients are encouraged to receive vaccination as the benefits outweigh the *** against COVID-19 is also recommended to family members and healthcare professionals caring for these patients to reduce exposure to the severe acute respiratory syndrome coronavirus 2 virus.

关键词： COVID-19 treatment Gastrointestinal side effects Hepatic side effects COVID-19 vaccine Chronic liver disease Liver transplantation